Role of single nucleotide Т786C polymorphism of endothelial NO-synthase gene after myocardial infarction with ST-segment elevation
Journal Title: Серце і судини - Year 2019, Vol 0, Issue 2
Abstract
The aim — of research was to investigate possible associations between single nucleotide T786C polymorphism of endothelial NO‑synthase (eNOS) gene and clinical events in acute period of myocardial infarction with ST segment elevation (STEMI) and after 6 months of follow‑up. Materials and methods. 177 patients with acute STEMI (139 (78.5 %) males and 38 (21.5 %) females) at average age 61.73 ± 9.44 years that were included to the study between January 2016 and July 2018 were examined. Primary percutaneous coronary intervention using bare‑metal stent (BMS) was performed in 133 patients. In 44 patients system thrombolyses were previously performed. All patients were able to achieve recovery of blood flow at TIMI III level. To determine the T786C polymorphism of the eNOS gene, polymerase chain reaction was used with an electrophoretic scheme for detecting the result in real time. The combined endpoint (repeated hospitalization, de novo heart failure, angina pectoris, cardiovascular death, which occurred 6 months after discharge from the hospital) was analyzed. Results and discussion. The combined endpoint was observed in 24 carriers of 786TT genotype of eNOS gene, in 23 individuals with the 786TC genotype and in 25 patients with 786CC genotype. Kaplan‑Meier curves showed that patients with STEMI carriers of 786CC genotype had a higher incidence of a combined endpoint than individuals with the 786TC and 786TT genotypes after 6 months of follow‑up. Multivariate logistic regression analysis revealed that the 786CC polymorphism of eNOS gene is an independent predictor of adverse clinical events 6 months after STEMI. Conclusions. Along with traditional risk factors (SYNTAX score, TIMI score, abdominal obesity) 786СС polymorphism of eNOS gene was found as an independent predictor for adverse cardiovascular events in 6‑month observation period after successful primary percutaneous coronary intervention in STEMI patients.
Authors and Affiliations
O. V. Petyunina, M. P. Kopytsya, A. E. Berezin, D. P. Babichev
Keywords
Related Articles
- EP ID EP608225
- DOI 10.30978/HV2019-2-63
- Views 139
- Downloads 0
Clinical, demographic and instrumental characteristics of patients with chronic heart failure and reduced left ventricular ejection fraction depending on iron deficiency
The aim — to establish clinical and other factors associated with iron deficiency (ID) in patients with chronic heart failure (CHF) and reduced left ventricular (LV) ejection fraction (EF). Materials and methods. 134 st...
Risk of heart rhythm disorders in patients with chronic obstructive pulmonary disease, combined with ischemic heart disease during computer spirography
The aim — to evaluate the safety of spirography with bronchodilation test in patients with a combination of stable ischemic heart disease (IHD) and chronic obstructive pulmonary disease (COPD). Materials and methods. 14...
Peripheral blood leukocyte count and prognosis in patients with myocardial infarction treated with thrombolytic therapy
The aim — to evaluate the predictive value of peripheral blood leukocyte count regarding the efficacy of thrombolytic therapy (TLT) and STEMI clinical course. Materials and methods. We examined 100 patients with STEMI a...
Register of percutaneous coronary interventions. Are changes for 2015 — 2018 a casual splash of activities or system transformations?
The Register of Percutaneous Coronary Interventions (PCI) was created in 2010 by the all‑Ukrainian non‑governmental organization «Association of Interventional Cardiologists of Ukraine». As of 03.08.2019, 19 h 48 min, 12...
Acute myocardial infarction in patients with diabetes mellitus: possibility and expediency of cardioprotection
The aim — to evaluate the efficacy and safety of addition of a solution containing 4.2 g of arginine hydrochloride and 2.0 g L‑carnitine to standard therapy of patients with acute coronary syndrome (ACS) with ST segment...